RediNews
ETFs Holding RPTP »    RPTP Historical Stock Prices »
RPTP News Video: Mon, Sep 12, 2016, 3:13 PM — Monday Sector Leaders: Precious Metals, Drugs


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Raptor Pharmaceuticals is a biopharmaceutical company engaged in developing and commercializing therapeutics that treat debilitating and often fatal diseases. Co.'s product includes: PROCYSBI® (cysteamine bitartrate) delayed-release capsules, for the management of nephropathic cystinosis in adults and children six years and older. Co.'s other clinical-stage product candidates include RP103, which contains, cysteamine bitartrate, and utilizes Co.'s proprietary capsule formulation containing delayed-release enteric coated microbeads of cysteamine bitartrate. Co.'s preclinical candidates include include RP105 and RP 106 being developed for a range of rare diseases. Self directed investors in Raptor Pharmaceuticals Corp. will be interested in keeping up with all Raptor Pharmaceuticals Corp. news they can find, both RPTP news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on RPTP. At RediNews, we simplify this task by presenting both RPTP news releases originating from Raptor Pharmaceuticals Corp. itself, and RPTP news from a variety of media outlets. Visitors can browse this news online and through our RPTP RSS news feed.

RPTP News

RPTP News — Articles, Videos, & Press Releases

RPTP is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

TFX News
INCY News
ICUI News
RGEN News
SYK News
MDVN News
EXAS News
HMA News
MMSI News
VOLC News

RediNews invites you to integrate our free RSS news feeds. While web portal content experience like building out an investor relations web site is a major plus when working with our RSS feeds, you don't need stock quote feed experience to begin working with something as simple as RSS — which stands for Really Simple Syndication. Although such experience could lead to some great custom market content ideas like a custom stock ticker with related news included, you don't need to be at the level of head of IR content for an IR services firm to work with our feeds. And unlike investor relations data feeds that typically carry steep licensing feeds, our RediNews RSS feeds are provided to you free of charge. To give our feeds a try, look for the RSS icon for any news page (which will look like this): .

RPTP News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.